BRCA testing: ethics lessons for the new genetics

Sherwin, Susan
February 2004
Clinical & Investigative Medicine;Feb2004, Vol. 27 Issue 1, p19
Academic Journal
Focuses on ethical lessons on breast cancer (BRCA) testing. Benefits of the development of tests for genetic susceptability to particular disease; Importance of taking BRCA test; Factors making it difficult for patients and medical experts to determine morally appropriate responses to the availability of BRCA testing; Level of public awareness on the availability of the test.


Related Articles

  • Ethical, Social and Economic Issues in Familial Breast Cancer: a compilation of views from the E.C. Biomed II Demonstration Project. Steel, Michael; Smyth, Elizabeth; Vasen, Hans; Eccles, Diana; Evans, Gareth; Møller, Pål; Hodgson, Shirley; Stoppa-Lyonnet, Dominique; Chang-Claude, Jenny; Caligo, Maria; Morrison, Patrick; Haites, Neva // Disease Markers;1999, Vol. 15 Issue 1/3, p125 

    Demand for clinical services for familial breast cancer is continuing to rise across Europe.  Service provision is far from uniform and, in most centres, its evolution has been determined by local conditions, specifically by local research interests, rather than by central...

  • Ethical issues in autologous stem cell transplantation (ASCT) in advanced breast cancer: A systematic literature review. Droste, Sigrid; Herrmann-Frank, Annegret; Scheibler, Fueloep; Krones, Tanja // BMC Medical Ethics;2011, Vol. 12 Issue 1, p6 

    Background: An effectiveness assessment on ASCT in locally advanced and metastatic breast cancer identified serious ethical issues associated with this intervention. Our objective was to systematically review these aspects by means of a literature analysis. Methods: We chose the reflexive...

  • Overdiagnosis in Breast Cancer Screening: Time to Tackle an Underappreciated Harm. Elmore, Joann G.; Fletcher, Suzanne W. // Annals of Internal Medicine;4/3/2012, Vol. 156 Issue 7, p536 

    The authors offer opinions on the overdiagnosis of breast cancer. They argue that unnecessary mammography screening may cause harmless conditions to be treated as cancer, with serious negative impact on the patient. A related example of medical screening leading to overdiagnosis is cited,...

  • TMEM17 promotes malignant progression of breast cancer via AKT/GSK3β signaling. Zhao, Yue; Song, Kuiyuan; Zhang, Yong; Xu, Hongtao; Zhang, Xiupeng; Wang, Liang; Fan, Chuifeng; Jiang, Guiyang; Wang, Enhua // Cancer Management & Research;Aug2018, Vol. 10, p2419 

    Purpose: Current knowledge of TMEM17, a recently identified protein of the transmembrane (TMEM) family, is limited, especially with respect to its expression and biological functions in malignant tumors. This study analyzed TMEM17 expression in invasive breast cancer tissue and breast cell lines...

  • MEPs shun cancer advocacy group because of funding by the pharmaceutical industry. Stafford, Ned // BMJ: British Medical Journal (International Edition);5/3/2008, Vol. 336 Issue 7651, p980 

    The article reports on a 2008 decision of the European parliamentary group on breast cancer to cut its ties with a breast cancer advocacy group called Europa Donna. The group made the decision after determining that the group accepted financial support from drug companies in the pharmaceutical...

  • "Evidence of me" in evidence based medicine? Lockwood, Susan // BMJ: British Medical Journal (International Edition);10/30/2004, Vol. 329 Issue 7473, p1033 

    Looks at the role of patients' values in evidence-based medicine. Contrast of a clinician's use of rational, objective evidence in decision-making with a patient's reliance on emotional, relational, and subjective evidence; Discussion of evidence-based medicine from the perspective of breast...

  • Neglected Breast Masses. Starr, David S. // Cortlandt Forum;06/25/2001, Vol. 14 Issue 6, p48 

    Presents a case on medical negligence resulting to a development of cancer in a female medical student. Accounts of patient visits to the physician; Laboratory procedures performed on the patient; Decision of the jury regarding the damages concurred by the patient.

  • Genome-Wide Association Study of Breast Cancer in the Japanese Population. Low, Siew-Kee; Takahashi, Atsushi; Ashikawa, Kyota; Inazawa, Johji; Miki, Yoshio; Kubo, Michiaki; Nakamura, Yusuke; Katagiri, Toyomasa // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Breast cancer is the most common malignancy among women in worldwide including Japan. Several studies have identified common genetic variants to be associated with the risk of breast cancer. Due to the complex linkage disequilibrium structure and various environmental exposures in different...

  • Genetic medicine: ethical and practical issues of application of the new technology. Kotalik, Jaro; Silverman, Melvin // Clinical & Investigative Medicine;Feb2004, Vol. 27 Issue 1, p14 

    Discusses a symposium on ethical and practical issues on the application of technology in genetic medicine. Presentation by physician David Cole about ovarian cancer; Concern of Doctor Susan Sherwin about the difficulty in making accurate predictions of personal risk and the influence of the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics